Handelsavisen
prelaunch
Companies ›Financials ›CNTN
CN
CNTN — Nasdaq Insurance

Canton Strategic Holdings, Inc.

$2,02
Open in Charts → Attach watcher ⌖
— —
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
418,7M USD
P/E
—
EV / Rev
—
Div yield
—
Op margin
—
ROE
-10,1 %
Net margin
—
Debt / equity
—
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
$2,06
Open
—
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About

Canton Strategic Holdings, Inc. is classified under Financials / Insurance and appears not currently profitable on the latest normalized snapshot.

Business. Canton Strategic Holdings, Inc. (CNTN) is a multiline insurance and brokerage firm operating within the insurance industry. The company is headquartered in the United States and is listed on the Nasdaq stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification77 %
SectorFinancials
Business sectorInsurance
ActivityMultiline Insurance & Brokers
Generated · rules-based
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership→
Geode Capital Management, L.L.C.
largest disclosed fund holder
Profitability→
-10,1 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning CNTN.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CNTN. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Canton Strategic Holdings, Inc. (CNTN) is a multiline insurance and brokerage firm operating within the insurance industry. The company is headquartered in the United States and is listed on the Nasdaq stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification77 %
    SectorFinancials
    Business sectorInsurance
    ActivityMultiline Insurance & Brokers
    AI synthesis
    GENERATED

    Canton Strategic Holdings, Inc. (CNTN) is currently classified as Multiline Insurance & Brokers within Insurance (Financials). Classification confidence: 0.77 (rule-based classification). Capital structure on the latest snapshot: total assets 584,654,613 USD, total equity 469,799,318, short-term debt 0, long-term debt 0. Net cash position is approximately 7,610,340 USD. Self-calculated market cap is 402,949,456 USD (market_price × shares_outstanding_diluted). Profitability profile: revenue 0, gross profit 0, operating income -36,868,311, net income -47,343,197. Return on equity ~-10.1%. Return on assets ~-8.1%. Operating-cash-flow to net-income ratio is 0.16. Risk profile from automated assessment: liquidity risk high, dilution risk high. Flags: Diluted share count is materially above the basic share count.; Filings reference going-concern or substantial-doubt language.; Source documents mention dilution or offering risk.. Recent news context: [TRIGGER] 8-K: 8-K (sec_8k_material) on CNTN — filing_type=8-K; max_severity=critical; ignored_items=['8.01', '9.01']; material_items=['1.01', '2.01']; all_items_found=['1.01', '2.01', '8.01', '9.01']; severity_per_code={'1.01': 'high', '2.01': 'critical'}; contributing_watchers=sec_8k_material (source=sec_8k_material; url=0001493152-26-034340). Additional context: 8-K: filing_type=8-K; max_severity=critical; ignored_items=['8.01', '9.01']; material_items=['1.01', '2.01']; all_items_found=['1.01', '2.01', '8.01', '9.01']; severity_per_code={'1.01': 'high', '2.01': 'critical'}; contributing_watchers=sec_8k_material.

    Key takeaways
    • Return on equity is about -10.1%.
    • Debt to equity is about 0.0x.
    • [TRIGGER] 8-K: 8-K (sec_8k_material) on CNTN — filing_type=8-K; max_severity=critical; ignored_items=['8.01', '9.01']; material_items=['1.01', '2.01']; all_items_found=['1.01', '2.01', '8.01', '9.01']; severity_per_code={'1.01': 'high', '2.01': 'critical'}; contributing_watchers=sec_8k_material (source=sec_8k_material; url=0001493152-26-034340)
    • Companyfacts coverage was partial; recent filing facts backfilled cash_and_equivalents.
    • false Q1 --12-31 0001861657 0001861657 2026-01-01 2026-03-31 0001861657 2026-05-11 0001861657 2026-03-31 0001861657 2025-12-31 0001861657 2025-01-01 2025-03-31 0001861657 us-gaap:CommonStockMember 2024-12-31 0001861657 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001861657 us-gaap:RetainedEarningsMember 2024-12-31 0001861657 us-gaap:TreasuryStockCommonMember 2024-12-31 0001861657 2024-12-31 0001861657 us-gaap:CommonStockMember 2025-12-31 0001861657 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001861657 us-gaap:RetainedEarningsMember 2025-12-31 0001861657 us-gaap:TreasuryStockCommonMember 2025-12-31 0001861657 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001861657 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001861657 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001861657 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001861657 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001861657 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001861657 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001861657 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0001861657 us-gaap:CommonStockMember 2025-03-31 0001861657 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001861657 us-gaap:RetainedEarningsMember 2025-03-31 0001861657 us-gaap:TreasuryStockCommonMember 2025-03-31 0001861657 2025-03-31 0001861657 us-gaap:CommonStockMember 2026-03-31 0001861657 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001861657 us-gaap:RetainedEarningsMember 2026-03-31 0001861657 us-gaap:TreasuryStockCommonMember 2026-03-31 0001861657 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001861657 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001861657 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001861657 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001861657 CNTN:CashSecuritiesPurchaseAgreementsMember 2025-11-03 2025-11-03 0001861657 CNTN:CashSecuritiesPurchaseAgreementsMember 2025-11-03 0001861657 CNTN:CashSecuritiesPurchaseAgreementsMember CNTN:PrefundedWarrantsMember 2025-11-03 0001861657 CNTN:CryptocurrencyOfferingMember CNTN:PrefundedWarrantsMember 2025-11-03 0001861657 CNTN:CryptocurrencyOfferingMember CNTN:PrefundedWarrantsMember 2025-11-03 2025-11-03 0001861657 CNTN:CashOfferingAndCryptocurrencyOfferingMember 2025-11-03 2025-11-03 0001861657 CNTN:CashOfferingAndCryptocurrencyOfferingMember 2025-11-03 0001861657 CNTN:CashSecuritiesPurchaseAgreementsAndCrytocurrencySecuritiesPurchaseAgreementsMember CNTN:StrategicAdvisorWarrantsMember 2025-11-03 0001861657 CNTN:TwoThousandTwentyFiveATMAgreementMember srt:MaximumMember 2025-11-06 2025-11-06 0001861657 CNTN:TwoThousandTwentyFiveATMAgreementMember 2025-01-01 2025-12-31 0001861657 CNTN:TwoThousandTwentyFiveATMAgreementMember 2025-12-31 0001861657 us-gaap:CommonStockMember 2026-01-21 2026-01-21 0001861657 us-gaap:CommonStockMember 2026-01-21 0001861657 CNTN:PrefundedWarrantsMember 2026-01-21 0001861657 2026-01-21 0001861657 2026-01-21 2026-01-21 0001861657 CNTN:MarchTwoThousandTwentySixATMAgreementMember 2026-03-03 2026-03-03 0001861657 CNTN:TwoThousandTwentyFiveATMAgreementMember 2026-01-01 2026-03-31 0001861657 CNTN:TwoThousandTwentyFiveATMAgreementMember 2026-03-31 0001861657 CNTN:TwoThousandSeventeenStockIncentivePlanMember 2026-03-31 0001861657 CNTN:TwoThousandSeventeenStockIncentivePlanMember 2026-01-01 2026-03-31 0001861657 CNTN:TwoThousandSeventeenStockIncentivePlanMember 2025-12-31 0001861657 CNTN:TwoThousandNineteenStockIncentivePlanMember 2026-01-01 2026-03-31 0001861657 CNTN:TwoThousandNineteenStockIncentivePlanMember 2026-03-31 0001861657 CNTN:TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember 2025-01-01 2025-01-01 0001861657 CNTN:TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember 2025-06-10 2025-06-10 0001861657 CNTN:TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember 2025-10-09 2025-10-09 0001861657 CNTN:TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember 2025-10-09 0001861657 CNTN:TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember 2026-01-29 2026-01-29 0001861657 CNTN:TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember 2026-01-30 2026-01-30 0001861657 CNTN:TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember 2026-01-01 2026-03-31 0001861657 CNTN:TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember 2025-01-01 2025-12-31 0001861657 CNTN:TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember 2026-03-31 0001861657 CNTN:StrategicAdvisorWarrantsMember 2026-01-01 2026-03-31 0001861657 CNTN:StrategicAdvisorWarrantsMember 2026-03-31 0001861657 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-03-31 0001861657 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001861657 us-gaap:RestrictedStockUnitsRSUMember 2026-03-31 0001861657 2025-01-01 2025-12-31 0001861657 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001861657 us-gaap:EmployeeStockOptionMember 2025-03-31 0001861657 CNTN:ResearchAndDevelopmentExpensesMember 2026-01-01 2026-03-31 0001861657 CNTN:ResearchAndDevelopmentExpensesMember 2025-01-01 2025-03-31 0001861657 CNTN:GeneralAndAdministrativeExpensesMember 2026-01-01 2026-03-31 0001861657 CNTN:GeneralAndAdministrativeExpensesMember 2025-01-01 2025-03-31 0001861657 CNTN:WarrantsOneMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsOneMember 2026-03-31 0001861657 CNTN:WarrantsTwoMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsTwoMember 2026-03-31 0001861657 CNTN:WarrantsThreeMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsThreeMember 2026-03-31 0001861657 CNTN:WarrantsFourMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsFourMember 2026-03-31 0001861657 CNTN:WarrantsFiveMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsFiveMember 2026-03-31 0001861657 CNTN:WarrantsSixMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsSixMember 2026-03-31 0001861657 CNTN:WarrantsSevenMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsSevenMember 2026-03-31 0001861657 CNTN:WarrantsEightMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsEightMember 2026-03-31 0001861657 CNTN:WarrantsNineMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsNineMember 2026-03-31 0001861657 CNTN:WarrantsTenMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsTenMember 2026-03-31 0001861657 CNTN:WarrantsElevenMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsElevenMember 2026-03-31 0001861657 CNTN:WarrantsTwelveMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsTwelveMember 2026-03-31 0001861657 CNTN:WarrantsThirteenMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsThirteenMember 2026-03-31 0001861657 CNTN:WarrantsFourteenMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsFourteenMember 2026-03-31 0001861657 CNTN:WarrantsFifteenMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsFifteenMember 2026-03-31 0001861657 CNTN:WarrantsSixteenMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsSixteenMember 2026-03-31 0001861657 CNTN:WarrantsSeventeenMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsSeventeenMember 2026-03-31 0001861657 CNTN:WarrantsEighteenMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsEighteenMember 2026-03-31 0001861657 CNTN:WarrantsNineteenMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsNineteenMember 2026-03-31 0001861657 CNTN:WarrantsTwentyMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsTwentyMember 2026-03-31 0001861657 CNTN:WarrantsTwentyOneMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsTwentyOneMember 2026-03-31 0001861657 CNTN:WarrantsTwentyTwoMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsTwentyTwoMember 2026-03-31 0001861657 CNTN:WarrantsTwentyThreeMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsTwentyThreeMember 2026-03-31 0001861657 CNTN:WarrantsTwentyFourMember 2026-01-01 2026-03-31 0001861657 CNTN:WarrantsTwentyFourMember 2026-03-31 0001861657 2023-01-01 2023-01-31 0001861657 CNTN:MinotaurAgreementMember 2026-01-01 2026-03-31 0001861657 CNTN:MinotaurAgreementMember 2025-01-01 2025-03-31 0001861657 CNTN:AppliedBiomedicalScienceInstituteMember 2023-07-27 2023-07-27 0001861657 CNTN:ABSIMember 2023-07-04 2023-07-05 0001861657 CNTN:AppliedBiomedicalScienceInstituteMember srt:MaximumMember 2023-07-04 2023-07-05 0001861657 2024-03-11 2024-03-11 0001861657 CNTN:AppliedBiomedicalScienceInstituteMember 2026-01-01 2026-03-31 0001861657 CNTN:AppliedBiomedicalScienceInstituteMember 2025-01-01 2025-03-31 0001861657 CNTN:IntractPatentLicenseAgreementMember 2023-11-03 2023-11-03 0001861657 srt:MaximumMember 2023-11-03 2023-11-03 0001861657 CNTN:AviorPatentLicenseAgreementMember 2026-01-01 2026-03-31 0001861657 CNTN:AviorPatentLicenseAgreementMember 2025-01-01 2025-03-31 0001861657 CNTN:EnkefalosLicenseAgreementMember 2024-06-17 2024-06-17 0001861657 CNTN:EnkefalosLicenseAgreementMember 2026-01-01 2026-03-31 0001861657 CNTN:EnkefalosLicenseAgreementMember 2025-01-01 2025-03-31 0001861657 CNTN:IntractPatentLicenseAgreementMember 2024-09-11 2024-09-11 0001861657 CNTN:IntractPatentLicenseAgreementMember 2025-01-01 2025-06-30 0001861657 CNTN:IntractPatentLicenseAgreementMember 2026-01-01 2026-03-31 0001861657 CNTN:IntractPatentLicenseAgreementMember 2025-01-01 2025-03-31 0001861657 us-gaap:RelatedPartyMember CNTN:PresidentStreetGlobalMember 2025-12-31 0001861657 CNTN:DigitalAssetTreasuryMember 2026-03-31 0001861657 CNTN:DigitalAssetTreasuryMember 2025-12-31 0001861657 CNTN:ClinicalStageBioTechnologyMember 2026-03-31 0001861657 CNTN:ClinicalStageBioTechnologyMember 2025-12-31 0001861657 CNTN:DigitalAssetTreasuryMember 2026-01-01 2026-03-31 0001861657 CNTN:DigitalAssetTreasuryMember 2025-01-01 2025-03-31 0001861657 CNTN:ClinicalStageBioTechnologyMember 2026-01-01 2026-03-31 0001861657 CNTN:ClinicalStageBioTechnologyMember 2025-01-01 2025-03-31 0001861657 CNTN:TwoThousandTwentyFiveATMAgreementMember us-gaap:SubsequentEventMember 2026-04-01 2026-05-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure CNTN:Integer CNTN:Segment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-31
    Q4 2025 · Quarter highlights
    Open report →

    Operating income -$36.9M.

    Revenue—
    Operating income-$36.9M
    Net income-$47.3M
    Free cash flow—
    EPS—
    Operating cash flow-$7.6M
    Financials
    Income statement
    Revenue—
    Gross profit—
    Operating income-$36.9M
    Net income-$47.3M
    Balance sheet
    Total assets$584.7M
    Total liabilities$114.9M
    Total equity$469.8M
    Cash & equivalents—
    Long-term debt—
    Cash flow
    Operating cash flow-$7.6M
    CapEx—
    Free cash flow—
    SBC$32.3M
    Highlights
    • ▍Operating income -$36.9M

    Valuation FY

    Market price
    $2,02
    Market cap
    $402.9M
    Enterprise valueⓘ
    $395.3M
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    0.9x
    P / Tangible bookⓘ
    0.9x
    Tangible book
    $469.8M
    Net cashⓘ
    $7.6M
    Current ratioⓘ
    37.8
    Debt / equityⓘ
    —
    ROAⓘ
    -8.1%
    ROEⓘ
    -10.1%
    Cash conversionⓘ
    16.0%
    CapEx / revenueⓘ
    —
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    2.7%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskHigh
    Liquidity riskHigh
    Filing-based flags
    • Diluted share count is materially above the basic share count.
    • Filings reference going-concern or substantial-doubt language.
    • Source documents mention dilution or offering risk.

    Benchmarks vs cohort

    ROE-10,1 %Bottom quartile
    D/E0,00Above median
    Cash Conv0,16Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 405 000 sh10 grants8 insiders
    • Liddy James GordonDirector · Stock Option → Common StockAcquired 5 000 @ $3,08grant · 2025-11-03
    • Parikh SanamDirector, COO · Stock Option → Common StockAcquired 5 000 @ $3,08grant · 2025-11-03
    • Appajosyula SireeshDirector, CEO · Stock Option → Common StockAcquired 20 000 @ $3,08grant · 2025-11-03
    • LoPriore Vincent SDirector, Executive Chairman, 10% owner · Stock Option → Common StockAcquired 90 000 @ $3,08grant · 2025-11-03
    • Rickel Nancy DavisDirector · Stock Option → Common StockAcquired 5 000 @ $3,08grant · 2025-11-03
    • Stetz Gary S.Director · Stock Option → Common StockAcquired 32 500 @ $3,08grant · 2025-11-03
    • Gravitas Capital LP10% owner · Stock Option → Common StockAcquired 90 000 @ $3,08grant · 2025-11-03
    • Kahler Thomas ClayDirector · Stock Option → Common StockAcquired 17 500 @ $3,08grant · 2025-11-03
    • Parikh SanamDirector · Stock Option → Common StockAcquired 50 000 @ $1,33grant · 2025-08-04
    • Appajosyula SireeshDirector, CEO · Stock Option → Common StockAcquired 90 000 @ $1,33grant · 2025-08-04

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Regulatory filings
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Return On Equity
      net_income / total_equity
    • Enterprise Value
      market_cap - net_cash
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • Canton Strategic Holdings, Inc. company facts · 2026-07-26
    • Canton Strategic Holdings, Inc. 10-Q 2026-05-13 · 2026-07-26
    • Canton Strategic Holdings, Inc. 10-K 2026-03-31 · 2026-07-26
    • Canton Strategic Holdings, Inc. 10-Q 2025-11-12 · 2026-07-26
    • Canton Strategic Holdings, Inc. 10-Q 2025-08-14 · 2026-07-26
    • 8-K (sec_8k_material) on CNTN · 2026-07-26

    Ownership & reference

    Top holders

    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$1M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$2M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$1M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    Net selling0 buys · 6 sellsnet -$258K1 insiders · last 365d
    • Stetz Gary S.Director · Common StockSold 12 500 @ $3,47$43K · 2026-05-26
    • Stetz Gary S.Director · Common StockSold 15 000 @ $3,41$51K · 2026-05-22
    • Stetz Gary S.Director · Common StockSold 15 000 @ $3,40$51K · 2026-05-22
    • Stetz Gary S.Director · Common StockSold 10 000 @ $3,40$34K · 2026-05-22
    • Stetz Gary S.Director · Common StockSold 12 851 @ $3,44$44K · 2026-05-22
    • Stetz Gary S.Director · Common StockSold 10 000 @ $3,45$34K · 2026-05-22

    Short positioning

    7.8Mshares short+11.4% vs prior
    11.84days to cover
    45.9%short of daily vol
    2.7Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CNTNCanonical
    Nasdaq · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskHigh
    Liquidity riskHigh
    Diluted share count is materially above the basic share count.
    Filings reference going-concern or substantial-doubt language.
    Source documents mention dilution or offering risk.

    Evidence & claims

    From filings & derived data
    • Current assets (annual): USD 17.39MUnknown
    • EPS (basic) (annual): USD-PER-SHARES -1Unknown
    • Total operating expenses (annual): USD 20.11MUnknown
    • Total liabilities (annual): USD 121.22MUnknown
    • Pre-tax income (annual): USD -42.1MUnknown
    • Total assets (annual): USD 519.15MUnknown
    • EPS (diluted) (annual): USD-PER-SHARES -1Unknown
    • Shares outstanding (annual): 37.11MUnknown
    • Shareholders' equity (annual): USD 397.93MUnknown
    • R&D expense (annual): USD 3.07MUnknown
    • Operating income (annual): USD -20.11MUnknown
    • Current liabilities (annual): USD 3.29MUnknown
    • Net income (annual): USD -35.92MUnknown
    • Operating cash flow (annual): USD -16.13MUnknown
    • Shares outstanding (annual): 1.97MUnknown
    • Current liabilities (annual): USD 2.41MUnknown
    • Operating income (annual): USD -12.43MUnknown
    • Total liabilities (annual): USD 2.41MUnknown
    • Shareholders' equity (annual): USD 1.31MUnknown
    • Pre-tax income (annual): USD -12.2MUnknown
    • Operating cash flow (annual): USD -10.9MUnknown
    • Net income (annual): USD -12.2MUnknown
    • EPS (diluted) (annual): USD-PER-SHARES -9Unknown
    • Cash & equivalents (annual): USD 3.56MUnknown
    Showing 24 of 29 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-24 04:31 UTCFILINGMaterial 8-K
    2026-06-16FILING8-K filing →
    2026-05-26 00:00 UTCINSIDER6 insider transactions — 2026-05 · net sell $258k
    2026-05-26INSIDERStetz Gary S. sold 12.5k sh — Director ~$43k
    2026-05-22INSIDERStetz Gary S. sold 15.0k sh — Director ~$51k
    2026-05-22INSIDERStetz Gary S. sold 10.0k sh — Director ~$34k
    2026-05-22INSIDERStetz Gary S. sold 12.9k sh — Director ~$44k
    2026-05-13FILING10-Q filing →
    2026-03-31EARNINGSQuarterly results — Q4 2025 Net USD -47.3M
    2026-03-31FILING10-K filing →
    2026-03-31FILING8-K filing →
    2026-03-03FILING8-K filing →
    2026-03-03FILING424B5 filing →
    2026-03-03FILING8-K filing →
    2026-02-18FILING8-K filing →
    2026-02-06FILING8-K filing →
    2026-02-02FILING8-K filing →
    2026-01-26FILING8-K filing →
    2026-01-22FILING8-K filing →
    2025-12-31EARNINGSQuarterly results — Q3 2025
    2025-12-31EARNINGSAnnual results — FY 2025 Net USD -35.9M
    2025-11-03 00:00 UTCINSIDER8 insider transactions — 2025-11 8 derivative
    2025-11-03INSIDERLiddy James Gordon acquired 5.0k sh Stock Option — Director
    2025-11-03INSIDERParikh Sanam acquired 5.0k sh Stock Option — Director, COO
    2025-11-03INSIDERRickel Nancy Davis acquired 5.0k sh Stock Option — Director
    2025-11-03INSIDERLoPriore Vincent S acquired 90.0k sh Stock Option — Director, Executive Chairman, 10% owner
    2025-11-03INSIDERAppajosyula Sireesh acquired 20.0k sh Stock Option — Director, CEO
    2025-11-03INSIDERKahler Thomas Clay acquired 17.5k sh Stock Option — Director
    2025-11-03INSIDERGravitas Capital LP acquired 90.0k sh Stock Option — 10% owner
    2025-11-03INSIDERStetz Gary S. acquired 32.5k sh Stock Option — Director
    2025-09-30EARNINGSQuarterly results — Q2 2025 Net USD -6.5M
    2025-08-04 00:00 UTCINSIDER2 insider transactions — 2025-08 2 derivative
    2025-08-04INSIDERParikh Sanam acquired 50.0k sh Stock Option — Director
    2025-08-04INSIDERAppajosyula Sireesh acquired 90.0k sh Stock Option — Director, CEO
    2025-06-30EARNINGSQuarterly results — Q1 2025 Net USD -4.4M
    2025-06-23 00:00 UTCINSIDER3 insider transactions — 2025-06 · net buy $501k
    2024-12-31EARNINGSAnnual results — FY 2024 Net USD -12.2M
    2023-12-31EARNINGSAnnual results — FY 2023 Net USD -9.3M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage